ace-083
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02257489)
Timeline
Indications
Mechanism of action
- Growth/differentiation factor 8ACTIVATOR
MSTN activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ace-083
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03943290 | Phase 2 | May 10, 2019 | Acceleron Pharma, Inc. |
| NCT03124459 | Phase 2 | Jun 1, 2017 | Acceleron Pharma, Inc. |
| NCT02927080 | Phase 2 | Nov 1, 2016 | Acceleron Pharma, Inc. |
| NCT02257489 | Phase 1 | Sep 1, 2014 | Acceleron Pharma, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Acceleron Pharma, Inc. | For profit | 4 | 4 | 2 | 2014 |
1 organizations
Page 1 / 1